ATE309805T1 - Verwendungsmethoden von makrozyklischen laktonen als mittel zur umkehrung der mehrfach- medikamentresistenz in krebs- und anderen zellen - Google Patents

Verwendungsmethoden von makrozyklischen laktonen als mittel zur umkehrung der mehrfach- medikamentresistenz in krebs- und anderen zellen

Info

Publication number
ATE309805T1
ATE309805T1 AT98917538T AT98917538T ATE309805T1 AT E309805 T1 ATE309805 T1 AT E309805T1 AT 98917538 T AT98917538 T AT 98917538T AT 98917538 T AT98917538 T AT 98917538T AT E309805 T1 ATE309805 T1 AT E309805T1
Authority
AT
Austria
Prior art keywords
agent
macrocyclic lactone
cancer
cells
methods
Prior art date
Application number
AT98917538T
Other languages
English (en)
Inventor
Roger K Prichard
Jean-Francois Pouliot
Elias Georges
Original Assignee
Univ Mcgill
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Mcgill filed Critical Univ Mcgill
Application granted granted Critical
Publication of ATE309805T1 publication Critical patent/ATE309805T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/22—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT98917538T 1997-04-30 1998-04-29 Verwendungsmethoden von makrozyklischen laktonen als mittel zur umkehrung der mehrfach- medikamentresistenz in krebs- und anderen zellen ATE309805T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4516197P 1997-04-30 1997-04-30
US09/067,677 US6114376A (en) 1997-04-30 1998-04-28 Methods for using macrocyclic lactone compounds as multidrug resistance reversing agents in tumor and other cells
PCT/IB1998/000750 WO1998048813A1 (en) 1997-04-30 1998-04-29 Methods for using macrocyclic lactone compounds as multidrug resistance reversing agents in tumor and other cells

Publications (1)

Publication Number Publication Date
ATE309805T1 true ATE309805T1 (de) 2005-12-15

Family

ID=26722446

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98917538T ATE309805T1 (de) 1997-04-30 1998-04-29 Verwendungsmethoden von makrozyklischen laktonen als mittel zur umkehrung der mehrfach- medikamentresistenz in krebs- und anderen zellen

Country Status (10)

Country Link
US (1) US6114376A (de)
EP (1) EP0979089B1 (de)
AT (1) ATE309805T1 (de)
AU (1) AU744406B2 (de)
CA (1) CA2289086C (de)
DE (1) DE69832375T2 (de)
DK (1) DK0979089T3 (de)
ES (1) ES2252832T3 (de)
NZ (1) NZ500429A (de)
WO (1) WO1998048813A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6761657B2 (en) * 1996-12-19 2004-07-13 Cloyes Gear And Products, Inc. Roller chain sprocket with added chordal pitch reduction
AU9785698A (en) * 1997-10-02 1999-04-27 Microcide Pharmaceuticals, Inc. Fungal efflux pump inhibitors
IL123288A (en) * 1998-02-13 2001-05-20 Nds Ltd Electronic game guide system
US7284064B1 (en) 2000-03-21 2007-10-16 Intel Corporation Method and apparatus to determine broadcast content and scheduling in a broadcast system
US7167895B1 (en) 2000-03-22 2007-01-23 Intel Corporation Signaling method and apparatus to provide content on demand in a broadcast system
US7275254B1 (en) 2000-11-21 2007-09-25 Intel Corporation Method and apparatus for determining and displaying the service level of a digital television broadcast signal
US20020144265A1 (en) * 2001-03-29 2002-10-03 Connelly Jay H. System and method for merging streaming and stored content information in an electronic program guide
US20020144269A1 (en) * 2001-03-30 2002-10-03 Connelly Jay H. Apparatus and method for a dynamic electronic program guide enabling billing broadcast services per EPG line item
US7185352B2 (en) * 2001-05-11 2007-02-27 Intel Corporation Method and apparatus for combining broadcast schedules and content on a digital broadcast-enabled client platform
US7055165B2 (en) * 2001-06-15 2006-05-30 Intel Corporation Method and apparatus for periodically delivering an optimal batch broadcast schedule based on distributed client feedback
US7020893B2 (en) * 2001-06-15 2006-03-28 Intel Corporation Method and apparatus for continuously and opportunistically driving an optimal broadcast schedule based on most recent client demand feedback from a distributed set of broadcast clients
US20020193066A1 (en) * 2001-06-15 2002-12-19 Connelly Jay H. Methods and apparatus for providing rating feedback for content in a broadcast system
US20020194585A1 (en) * 2001-06-15 2002-12-19 Connelly Jay H. Methods and apparatus for providing ranking feedback for content in a broadcast system
US7328455B2 (en) * 2001-06-28 2008-02-05 Intel Corporation Apparatus and method for enabling secure content decryption within a set-top box
US7363569B2 (en) * 2001-06-29 2008-04-22 Intel Corporation Correcting for data losses with feedback and response
US20030046683A1 (en) * 2001-08-28 2003-03-06 Jutzi Curtis E. Server-side preference prediction based on customer billing information to generate a broadcast schedule
US7047456B2 (en) * 2001-08-28 2006-05-16 Intel Corporation Error correction for regional and dynamic factors in communications
US7231653B2 (en) 2001-09-24 2007-06-12 Intel Corporation Method for delivering transport stream data
US8943540B2 (en) 2001-09-28 2015-01-27 Intel Corporation Method and apparatus to provide a personalized channel
WO2003041128A2 (en) * 2001-11-07 2003-05-15 Pharmacia Corporation Methods of promoting uptake and nuclear accumulation of polyamides in eukaryotic cells
US20030135857A1 (en) * 2002-01-11 2003-07-17 Ramesh Pendakur Content discovery in a digital broadcast data service
US20030135605A1 (en) * 2002-01-11 2003-07-17 Ramesh Pendakur User rating feedback loop to modify virtual channel content and/or schedules
US20030135553A1 (en) * 2002-01-11 2003-07-17 Ramesh Pendakur Content-based caching and routing of content using subscription information from downstream nodes
DE102007013765A1 (de) * 2007-03-22 2008-09-25 Studiengesellschaft Kohle Mbh Lejimalid Analoga und Verwendung davon
US20120225123A1 (en) * 2009-11-09 2012-09-06 University Health Network Use of Synergistic Combinations of an Avermectin and an Antineoplastic Compounds for the Treatment of Hematological Malignancies
US9351988B2 (en) 2011-05-02 2016-05-31 Universite De Geneve Macrocyclic lactones and use thereof
CA2895289C (en) * 2011-12-20 2020-06-30 Peter Falk Synergistic combination comprising avermectins and a nsaid for tumor inhibition
US20140271812A1 (en) * 2013-03-14 2014-09-18 Panacea Pharmaceuticals Treatment for chemotherapy-induced cognitive impairment
CN112898224B (zh) * 2019-12-04 2023-02-17 中国科学院上海药物研究所 一种烯丙基醇支撑的大环内酯化合物及其用途
CN115227691B (zh) * 2022-06-15 2023-05-05 福建卫生职业技术学院 源于细曲霉的内酯类化合物在抗人乳腺癌药物中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3950360A (en) * 1972-06-08 1976-04-13 Sankyo Company Limited Antibiotic substances
SE434277B (sv) * 1976-04-19 1984-07-16 Merck & Co Inc Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis
US4199569A (en) * 1977-10-03 1980-04-22 Merck & Co., Inc. Selective hydrogenation products of C-076 compounds and derivatives thereof
US5169956A (en) * 1984-06-05 1992-12-08 American Cyanamid Company Macrolide antibiotic compounds
US5106994A (en) * 1984-06-05 1992-04-21 American Cyanamid Company Agents and method of production thereof
US4916154A (en) * 1986-09-12 1990-04-10 American Cyanamid Company 23-Imino derivatives of LL-F28249 compounds
JPH04235126A (ja) * 1991-01-09 1992-08-24 Nippon Kayaku Co Ltd 耐性癌細胞に対する感受性増強剤
WO1994022846A1 (en) * 1993-03-30 1994-10-13 Pfizer Inc. Compounds enhancing antitumor activity of other cytotoxic agents
US5786344A (en) * 1994-07-05 1998-07-28 Arch Development Corporation Camptothecin drug combinations and methods with reduced side effects
US5578637A (en) * 1995-05-03 1996-11-26 University Of Washington Methods of inhibition or killing cancer cells using an endoperoxide

Also Published As

Publication number Publication date
EP0979089A1 (de) 2000-02-16
ES2252832T3 (es) 2006-05-16
CA2289086A1 (en) 1998-11-05
EP0979089B1 (de) 2005-11-16
AU744406B2 (en) 2002-02-21
DE69832375D1 (de) 2005-12-22
NZ500429A (en) 2001-05-25
DE69832375T2 (de) 2006-06-01
DK0979089T3 (da) 2005-12-12
AU7073698A (en) 1998-11-24
US6114376A (en) 2000-09-05
CA2289086C (en) 2008-07-15
WO1998048813A1 (en) 1998-11-05

Similar Documents

Publication Publication Date Title
ATE309805T1 (de) Verwendungsmethoden von makrozyklischen laktonen als mittel zur umkehrung der mehrfach- medikamentresistenz in krebs- und anderen zellen
CA2222680A1 (en) Endoparasiticidal agents
EA200100097A1 (ru) Составы для борьбы с человеческими вшами
CA2233016A1 (en) Anthelmintic macrocyclic lactone compositions
CA2275657A1 (en) Endoparasiticidal and ectoparasiticidal agents
AU747599C (en) Antitumor agents
RU94029662A (ru) Фосфонооксиметиловые эфиры производных таксана, фармацевтическая композиция, способы лечения
AR022860A1 (es) Derivados de camptotecina que poseen actividad antitumoral
ATE401330T1 (de) 2,3-olefinische epothilon-derivate
EE9900156A (et) Kondenseerunud 1-bensüül-3-(asendatud heteroarüül)pürasooli derivaadid
KR960000924A (ko) 인슐린 유사체 배합물
BR9811818A (pt) Uso de um composto, composto, e, composição farmacêutica
MX9200965A (es) Composicion dermatologica para el tratamiento de los onicomicosis.
DE69713151D1 (de) Cyclosporinderivat, dessen herstellung und pharmazeutische zusammensetzung
ATE242783T1 (de) Glycopeptid-derivate und pharmazeutische zusammensetzungen, die sie enthalten
HN1998000143A (es) Tetrahidronaftalenos substituidos y compuestos analogos.
AU2874099A (en) Low molecular weight compounds administered together with anti-cancer agents to treat cancer and pharmaceutical compositions thereof
DK1067933T3 (da) Semisyntetiske ecteinascidiner
DK0930077T3 (da) Cyclodextrinpræparater indeholdende et avermectin- eller milbemycinderivat
KR890701736A (ko) 과산화물 분자변위보효소의 포합체
EP1157698A3 (de) Behandlung von entzündlichen Erkrankungen mit Oxypurinnukleosiden
BR0008302A (pt) Uso de um derivado de benzaldeìdo, derivado de benzaldeìdo, composição farmacêutica, e, processo para a fabricação da mesma
EP1834670A3 (de) Avermectinen oder Milbemycine und bis-Aryl-Derivate enthaltende Anthelminthische Zusammensetzungen.
AU737680C (en) Novel compounds having antiviral activity
BRPI0413410A (pt) co-administração de um polissacarìdeo com um agente quimioterapêutico para o tratamento de cáncer

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0979089

Country of ref document: EP

REN Ceased due to non-payment of the annual fee